University of Colorado- Dept of Ophthalmology — Aurora, Colorado

University of Colorado- Dept of Ophthalmology is a clinical research site located in Aurora, Colorado, United States 80045.

Crixeo Clinical Trials Trust Score: 86/100 (GOOD). This profile has not yet been claimed by the site owner.

University of Colorado- Dept of Ophthalmology has participated in 5 clinical trials.

Therapeutic areas: Thyroid Eye Disease, Leber Hereditary Optic Neuropathy (LHON), Neurotrophic Keratitis.

Sponsors: Viridian Therapeutics, Inc., Neurophth Therapeutics Inc, Claris Biotherapeutics, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Aurora

Browse all research sites in Colorado · View every site in Aurora

Sponsor Feasibility Report

Trust Score: 86/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Colorado- Dept of Ophthalmology?

University of Colorado- Dept of Ophthalmology has a Crixeo Trust Score of 86/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Colorado- Dept of Ophthalmology conducted?

University of Colorado- Dept of Ophthalmology has 5 clinical trials on record. Their work covers Thyroid Eye Disease, Leber Hereditary Optic Neuropathy (LHON), Neurotrophic Keratitis.

Is University of Colorado- Dept of Ophthalmology accredited by Crixeo Clinical Trials?

University of Colorado- Dept of Ophthalmology has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of Colorado- Dept of Ophthalmology?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.